Antitumor effects of bevacizumab in combination with fluoropyrimidine drugs on human oral squamous cell carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Antitumor effects of bevacizumab in combination with fluoropyrimidine drugs on human oral squamous cell carcinoma

Published:2021-08-11 Issue:4 Volume:22 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Itashiki Yasutaka¹,Harada Koji¹,Takenawa Takanori¹,Ferdous Tarannum¹,Ueyama Yoshiya²,Mishima Katsuaki¹

Affiliation:

1. Department of Oral and Maxillofacial Surgery, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi 755‑8505, Japan

2. Department of Oral and Maxillofacial Surgery, Yamaguchi University, Ube, Yamaguchi 755‑8505, Japan

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of Cisplatin–CXCR4 Antagonist Combination Therapy in Oral Cancer;Cancers;2024-06-25

2. Direct antitumor activity of bevacizumab: an overlooked mechanism?;Frontiers in Pharmacology;2024-04-23

3. Combination Therapy as a Promising Way to Fight Oral Cancer;Pharmaceutics;2023-06-04

4. 3D-Printed Tumor-on-Chip for the Culture of Colorectal Cancer Microspheres: Mass Transport Characterization and Anti-Cancer Drug Assays;Bioengineering;2023-05-05

5. Combination Therapy in Cancer: Doxorubicin in Combination with an Nterminal Peptide of Endostatin Suppresses Angiogenesis and Stimulates Apoptosis in the Breast Cancer;INT J MOL CELL MED;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP